Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of deucravacitinib in active discoid lupus erythematosus and subacute cutaneous lupus erythematosus; results ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Discoid Lupus Erythematosus
• Subacute Cutaneous Lupus Erythematosus

Drugs mentioned

• Sotyktu (Deucravacitinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Lupus Erythematosus, Discoid, Lupus Erythematosus, Subacute Cutaneous | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-09-10